#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1794393	F	PUBCHEM_BIOASSAY: In Vitro MKP-3 Dose Response Assay for SAR Study. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1052, AID1661, AID2085, AID2679, AID425, AID553, AID566]		189		assay format	PubChem BioAssays
2.	ALA1613806	F	PUBCHEM_BIOASSAY: In Vitro HePTP Dose Response Colorimetric Assay for SAR Study. (Class of assay: confirmatory) [Related pubchem assays: 521 ]	Homo sapiens	112		assay format	PubChem BioAssays
3.	ALA1614063	B	PUBCHEM_BIOASSAY: GAPDH Dose Response Colorimetric Assay. (Class of assay: confirmatory)	Homo sapiens	744		single protein format	PubChem BioAssays
4.	ALA1614143	B	PUBCHEM_BIOASSAY: In Vitro Hsc70 Dose Response Fluorescence Polarization Assay. (Class of assay: confirmatory) [Related pubchem assays: 1072 ]	Homo sapiens	53		single protein format	PubChem BioAssays
5.	ALA1614297	B	PUBCHEM_BIOASSAY: In Vitro Hsp70 Dose Response Fluorescence Polarization Assay for SAR Study. (Class of assay: confirmatory) [Related pubchem assays: 786, 583 ]	Homo sapiens	52		single protein format	PubChem BioAssays
6.	ALA1614482	B	PUBCHEM_BIOASSAY: MKP-3 in vitro secondary assay for identification of irreversible and slow-binding inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1054, AID1055, AID425, AID553, AID566]	Rattus norvegicus	112		single protein format	PubChem BioAssays
7.	ALA4418829	B	Inhibition of ENTPD5 in PTEN knockout mouse MEF cells assessed as induction of ER stress by measuring increase in GRP78/BiP expression at 30 uM incubated for 24 hrs by Western blotting analysis	Mus musculus	31		cell-based format	Patent Bioactivity Data
8.	ALA4418833	F	Antitumor activity against human LNCAP cells xenografted in mouse assessed as induction of tumor shrinkage at 1 to 100 mg/kg, ip dosed every other day and measured after 6 weeks by microscopy	Homo sapiens	31		organism-based format	Patent Bioactivity Data
9.	ALA4418834	F	Antitumor activity against human LNCAP cells xenografted in mouse assessed as reduction in cells left in matrigels at 1 to 100 mg/kg, ip dosed every other day and measured after 6 weeks by hematoxylin and eosin staining based microscopy	Homo sapiens	31		organism-based format	Patent Bioactivity Data
10.	ALA4418835	B	Inhibition of human recombinant ENTPD5 expressed in insect cells assessed as reduction in UDP hydrolysis at 1 uM incubated for 1 hr in presence of UMP, GTP and ATP by Escherichia coli UMP kinase pyrH catalyzed UMP phosphorylation coupled luciferase assay	Homo sapiens	158		cell-based format	Patent Bioactivity Data
11.	ALA4418836	B	Inhibition of human recombinant ENTPD5 expressed in insect cells assessed as reduction in UDP hydrolysis up to 10 uM incubated for 1 hr in presence of UMP, GTP and ATP by Escherichia coli UMP kinase pyrH catalyzed UMP phosphorylation coupled luciferase assay	Homo sapiens	158		cell-based format	Patent Bioactivity Data
12.	ALA4418837	B	Inhibition of recombinant Escherichia coli UMP kinase pyrH catalyzed UMP phosphorylation in presence of GTP and ATP incubated for 1 hr by luminescence based assay	Escherichia coli	158		single protein format	Patent Bioactivity Data
13.	ALA4418838	B	Inhibition of human recombinant ENTPD5 expressed in insect cells assessed as reduction in reduction in UDP hydrolysis by measuring inorganic phosphate release incubated for 1 hr by malachite green based assay	Homo sapiens	158		cell-based format	Patent Bioactivity Data